Latest Articles

Lowering GVHD in Hematologic Malignancies
BY WAYNE KUZNAR
A new combination was shown to mitigate graft-versus-host disease (GVHD) for patients undergoing a hematopoietic stem cell transplant (HSCT).
Lymph Nodes Can Be Used to Plan Treatment for Head and Neck Cancer
BY ANGELICA WELCH
The number of positive lymph nodes can help guide treatment for  locally advanced head and neck cancer, according to a recent study.
Treatment Has High Response Rates in Aggressive Lymphoma
BY WAYNE KUZNAR
Axicabtagene ciloleucel had high response rates in patients with non-Hodgkin lymphoma in a phase 2 study.
Video Conferences May Be Effective in Nutritional Intervention of High-Risk Patients With Cancer
BY BRIELLE URCIUOLI
"Telenutrition" programs can help high-risk patients who do not otherwise have access to a registered dietician, according to a recent study and program launched at the Carolinas HealthCare System. 
Combination Regimen Benefits Genitourinary Cancers
BY STAFF WRITER
Cabometyx combinations showed activity in patients with GU cancers, according to a preliminary clinical study.
Expert Weighs in on Promising New Options for Frontline Kidney Cancer
BY ANGELICA WELCH
David McDermott, M.D. discusses new advances made to treat kidney cancer. 
FDA Gives Zykadia a Priority Review for Frontline Lung Cancer Treatment
BY JASON M. BRODERICK
The FDA granted Zykadia a priority review for the frontline treatment of some patients with lung cancer.
Personalizing Treatment With ctDNA in Prostate Cancer
BY JASON M. BRODERICK
Since it is found in the majority of patients with mCRPC, circulating tumor DNA may be able to lead the way to more personalized prostate cancer care.
Vyxeos Helps More Patients With AML Proceed to Transplant
BY SILAS INMAN
More people with AML who were treated with Vyxeos were moved to transplant than those treated with a standard chemotherapy regimen, according to recent findings.